BDSI


3 “Strong Buy” Healthcare Stocks Under $5 With Triple-Digit Growth Prospects

For those that thought the extreme market volatility was behind us, think again. This month, another burst of volatility was brought on by …

Company Update (NASDAQ:BDSI): Why BioDelivery Sciences International, Inc. Shares Are on the Ropes Today

BioDelivery Sciences International, Inc. (NASDAQ:BDSI) and Endo International (NASDAQ:ENDP) announced this morning that Clonidine Topical Gel failed to meet its primary endpoint in …

BioDelivery Sciences International, Inc. (BDSI) Shares Open Higher on Back of Top Analyst Upgrade

BioDelivery Sciences International, Inc. (NASDAQ:BDSI) shares are up 13% this morning, after Janney Montgomery analyst Ken Trbovich upgraded BDSI from a Neutral to a Buy rating …

Roth Capital Analysts Cut Price Targets for Galena Biopharma Inc (GALE) and BioDelivery Sciences International, Inc. (BDSI) But Remain Positive

Roth Capital analysts weighed in on Galena Biopharma Inc (NASDAQ:GALE) and BioDelivery Sciences International, Inc. (NASDAQ:BDSI) following Q4:15 earnings from both companies.

Biotech Roundup: Celldex Therapeutics, Inc. (CLDX), Keryx Biopharmaceuticals (KERX), BioDelivery Sciences International, Inc. (BDSI)

Biotech stocks are notoriously volatile as a pipeline update or FDA announcement can instantly send share prices through the roof. Below, analysts weigh …

Biotech Beat: Analysts Bullish On Relypsa Inc (RLYP) And BioDelivery Sciences International, Inc. (BDSI)

Healthcare analysts provided insight on both Relypsa Inc (NASDAQ:RLYP) and BioDelivery Sciences International, Inc. (NASDAQ:BDSI) with bullish outlooks.

Biotech Beat: Roth Capital Analysts Weigh In on Galena Biopharma Inc (GALE) and BioDelivery Sciences International, Inc. (BDSI)

Roth Capital analysts weigh in on the small-cap biotech company Galena Biopharma Inc (NASDAQ:GALE) and drug delivery company BioDelivery Sciences International, Inc. (NASDAQ:BDSI) after both companies …

Roth Capital Weighs In on BioDelivery Sciences International, Inc. (BDSI) Following Bunavail Supply Glitch

Roth Capital analyst Scott Henry weighed in today with his views on BioDelivery Sciences International, Inc.(NASDAQ:BDSI), after the company announced a supply constraint for its opioid dependence product …

DHHS to Expand Opioid Dependence Class; Additional Tailwind For BioDelivery Sciences’ Bunavail, Says William Blair

In a research report issued Friday, William Blair analyst Tim Lugo reiterated a Buy rating on shares of BioDelivery Sciences International, Inc. (NASDAQ:BDSI) with …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts